Evidence mapPaperPMID 40469229Full record

ArticleRSC advances2025

Synthesis, characterization and antidiabetic studies of novel amantadine-derived Schiff base (AHB) and its Zn(ii), Co(ii), Cr(iii) and VO(iv) complexes.

Aliya Ajaz, Muhammad Ashraf Shaheen, Muhammad Fayyaz Ur Rehman, Maqsood Ahmad, Khurram Shahzad Munawar, Abu Bakar Siddique, Muhammad Ashfaq, Nazir Ahmad

Abstract read
In one paragraph

Article in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Aliya AjazInstitute of Chemistry, University of Sargodha 40100 Pakistan ashraf.shaheen@uos.edu.pk.
Muhammad Ashraf ShaheenInstitute of Chemistry, University of Sargodha 40100 Pakistan ashraf.shaheen@uos.edu.pk.ORCID https://orcid.org/0000-0002-5578-5533
Muhammad Fayyaz Ur RehmanInstitute of Chemistry, University of Sargodha 40100 Pakistan ashraf.shaheen@uos.edu.pk.
Maqsood AhmadInstitute of Chemistry, The Islamia University of Bahawalpur Baghdad-ul-Jadeed Campus 63100 Pakistan.ORCID https://orcid.org/0000-0002-9700-3819
Khurram Shahzad MunawarInstitute of Chemistry, University of Sargodha 40100 Pakistan ashraf.shaheen@uos.edu.pk.ORCID https://orcid.org/0000-0001-9055-2519
Abu Bakar SiddiqueInstitute of Chemistry, University of Sargodha 40100 Pakistan ashraf.shaheen@uos.edu.pk.ORCID https://orcid.org/0000-0003-2834-5708
Muhammad AshfaqDepartment of Physics, University of Sargodha 42200 Pakistan.ORCID https://orcid.org/0000-0001-6663-8777
Nazir AhmadDepartment of Chemistry, Government College University Lahore 54000 Pakistan.ORCID https://orcid.org/0000-0002-5442-1682

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes mellitus is a significant health issue in Pakistan, with rising prevalence rates posing serious challenges to public health. To tackle this issue, several strategies have been developed recently, among which the controlled conversion of dietary carbohydrates into glucose by inhibition of enzymes is an appropriate strategy. For this purpose, many synthetic drugs have been tried and explored. In this scenario, a new Schiff base ligand, (

Identifiers

PMID40469229
PMCPMC12134986

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.